Skip to main content

Table 2 Summary of included studies (n = 35)

From: The effectiveness of champions in implementing innovations in health care: a systematic review

Characteristic

N (%) of studies or frequency (%)b

Publication year

2010–2020

24 (68.6%)

 

2000–2010

10 (28.6%)

 

1997

1 (2.9%)

Country

United States of America

22 (62.9%)

 

Canada

5 (14.3%)

 

England

1 (2.9%)

 

India

1 (2.9%)

 

Israel

1 (2.9%)

 

Italy

1 (2.9%)

 

Taiwan

1 (2.9%)

 

Uganda

1 (2.9%)

 

United States of America and Puerto Rico

1 (2.9%)

 

“18 European countries”

1 (2.9%)

Settinga

Acute care/tertiary

20 (57.1%)

 

Primary

11 (31.4%)

 

Community/Home

4 (11.4%)

 

Long-term Care

2 (5.7%)

Number of settings/institutions

One setting/institution

3 (8.6%)

 

2–10 settings/institutions

2 (5.7%)

 

11–50 settings/institutions

11 (31.4%)

 

51–100 settings/institutions

3 (8.6%)

 

101–500 settings/institutions

10 (28.6%)

 

 > 500 settings/institutions

2 (5.7%)

 

Not reported

4 (11.4%)

Study design

Cross-sectional

23 (65.7%)

 

Interrupted time series

3 (8.6%)

 

Non-controlled before and after

3 (8.6%)

 

Cohort

2 (5.7%)

 

Mixed methods (qualitative interview and cross-sectional)

1 (2.9%)

 

Case control

1 (2.9%)

 

Cluster randomised trial

1 (2.9%)

 

Mixed methods (qualitative interview and cohort)

1 (2.9%)

Study participantsa

Health care providers

17 (48.6%)

 

Patients

8 (22.9%)

 

Managers or administrators

5 (14.3%)

 

Not reported

7 (20%)

Sample size

1–100

2 (5.6%)

 

101–500

13 (36.1%)

 

501–1000

7 (19.4%)

 

 > 1000

6 (16.7%)

 

Not reported

8 (22.2%)

Sex and gender of study participants

Reported sex (n = # studies)

3 (8.3%)

Female

5052/8305 (60.8%)b

Male

3253/8305 (39.2%)b

 

Sex category interpreted as sex by extractor

3/3 (100%)

 

Reported gender identity (n = # studies)

10 (27.8%)

 

Female

5228/7026 (74.4%)b

 

Male

1771/7026 (25.2%)b

 

Non-binary

1/7026 (0.0%)b

 

Missing/Not reported

26/7026 (0.4%)b

 

Gender identity interpreted as sex by extractor

9/10 (90%)

 

Gender identity interpreted as gender by extractor

1/10 (10%)

 

Study did not specify if reported category was sex or gender identity (n = #studies)

2 (5.26%)

 

Male

3992/7047 (56.6%)

 

Female

3055/7047 (43.3%)

 

Interpreted as sex

2/2 (100%)

 

No report of sex or gender (n = #studies)

21 (58.3%)

  1. aSome studies are counted in more than one setting and study participants category; therefore, numbers do not add to n = 35 (100%);
  2. bData refers to frequency (%) of study participants rather than number (%) of studies.